TUESDAY, Feb. 13, 2018 -- Screening for ovarian cancer is not recommended for women with no signs or symptoms of the disease, newly released guidelines from the U.S. Preventive Services Task Force say.
That represents no change in advice from the 2012 guidelines or the task force's draft recommendations issued in the summer of 2017.
FRIDAY, Jan. 12, 2018 -- The U.S. Food and Drug Administration on Friday approved the first drug aimed at treating metastatic breast cancers linked to the BRCA gene mutation.
These mutated genes, called BRCA1 and BRCA2, first came to prominence in 2013 when actress and director Angelina Jolie announced she'd undergone a preventive double mastectomy. Jolie said she carried the BRCA1 gene, which greatly raises a woman's odds for breast and ovarian cancers.
MONDAY, Jan. 8, 2018 -- Women who pull the night shift regularly might be at greater risk for a number of cancers, new research suggests.
"Our study indicates that night-shift work serves as a risk factor for common cancers in women," said study author Xuelei Ma. He is an oncologist in the State Key Laboratory of Biotherapy and Cancer Center at West China Medical Center of Sichuan University, China.